RESULTS

141
The number of subjects in MRC dyspnea grade 2, 3, 4 and 5 was 16 (25%), 17 (26%), 17
142
(26%) and 15 (23%), respectively. Data for demographic variables, RVSP, pulmonary 143 function, arterial blood gas tensions, 6MWD and SF-36 subscale scores are shown in Table 1 .
144
Significant differences were observed between MRC dyspnea grade and time since diagnosis 145 of IPF, use of LTOT and oral corticosteroids, RSVP and pulmonary function (% predicted).
146
Post-hoc analyses revealed that the significant differences mostly were found between 147 subjects in dyspnea grade 2 and those in grades 3, 4 and 5 (Table 1) .
148
Six-minute walk distance showed a progressive and significant decline with increasing 149 MRC grade ( (Table 1 ).
166 Figure 1 shows data for muscle force, 6MWD, and ADL scores. All measures were 167 significantly lower in grade 4 and 5 subjects compared to subjects in grades 2 and 3 (p<0.01).
168
The associations between MRC grade and other measures are shown in The lower 6MWD with increasing MRC dyspnea grade suggests that functional exercise 
Study Limitations
210
Although the sample size in our study was greater than in other studies that have examined 211 the utility of the MRC dyspnea scale in subjects with IPF, 8-11 it was still relatively modest.
212
Measurement of daily physical activity or participation in an exercise regimen, and 213 identification of the presence of pulmonary hypertension via right heart catheterization,
214
would have been useful to evaluate their contribution to activity limitation in our subjects, 33 
215
but was beyond the scope of the study.
216
Large differences were observed in most variables when comparing subjects in dyspnea 
Clinical Implications
222
In subjects with IPF, the MRC dyspnea scale not only reflects the severity of activity 2.2 ± 0.6 1.9 ± 0.6 1.8 ± 0.6 1.5 ± 0.5 0.016 FVC, % predicted 83 ± 11 67 ± 13* 60 ± 16* 51 ± 11* † < 0.001 FRC, L 1.8 ± 0.4 1.7 ± 0.4 1.5 ± 0.6 1.3 ± 0.4 0.075 FRC, % predicted 73 ± 14 68 ± 11 58 ± 14* 55 ± 11* † < 0.001 TLC, L 3.6 ± 0.6 2.8 ± 0.7* 2.7 ± 0.8* 2.4 ± 0.6* < 0.001 TLC, % predicted 78 ± 11 61 ± 11* 54 ± 12* 49 ± 9* † < 0.001 DLCO, mL/min/mmHg 8.4 ± 2.5 5.8 ± 1.4* 4.4 ± 1.9* 3.5 ± 1.5* † < 0.001 DLCO, % predicted 58 ± 20 35 ± 10* 28 ± 12* † 21 ± 8* † < 0. .0 ± 12.0* < 0.001 Data are presented as means ± SD or number (n) and percentage (%) of subjects. BMI = body mass index; DLCO = diffusing capacity for carbon monoxide; FEV1 = forced expiratory volume in one second; FRC = functional residual capacity; FVC = forced vital capacity; LTOT = long term oxygen therapy; PaCO2 = arterial carbon dioxide tension; PaO2 = arterial oxygen tension; RVSP = right ventricular systolic pressure; 6MWD = 6-minute walk distance; TLC = total lung capacity; RVSP data missing for 3 subjects in Grade 2 and 1 subject in each of grades 3, 4 and 5. Arterial blood gas tensions measured breathing oxygen in subjects in LTOT or breathing room air. p values within the table refer to differences in group means or proportion of subjects. Significance level for undertaking post-hoc analyses as set at p<0.0017 [i.e. = 0.05/29 (where 29 = number of comparisons)]. Post-hoc analyses: *p<0.05 versus grade 2; † versus grade 3; ‡ versus grade 4. ADL = activities of daily living; DLCO = diffusing capacity for carbon monoxide; FVC = forced vital capacity; HF = handgrip force; QF = quadriceps force; RVSP = right ventricular systolic pressure; 6MWD = 6 minute walk distance; TLC = total lung capacity.
